3-D Matrix, Ltd. develops, manufactures, and sells self-assembling peptide technology in Japan and internationally. Its product, PuraMatrix, is a self-assembling peptide hydrogel used in regenerative medicine, cell therapy, drug delivery systems, and other applications across various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.